WHITEHAWK THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $56.00K, a 1020.00% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $5.00K.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $21.00K.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $2.00K, a 87.50% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $26.00K.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $78.00K, a 80.55% decline from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $401.00K, a 51.86% decline from fiscal 2021.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $833.00K, a 480.35% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $56.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $26.00K 10-K · filed 2026-03-12 | |
| 2025-06-30 | $5.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $21.00K 10-Q · filed 2026-08-06 | |
| 2023-12-31 | $78.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $68.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $8.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $401.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $136.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $244.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $833.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $745.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $10.19K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $70.28K 10-Q · filed 2021-08-11 | |
| 2020-12-31 | $143.53K 10-K · filed 2021-03-11 | |
| 2018-12-31 | $76.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $76.83K 10-K · filed 2020-03-16 |
| 2018-09-30 | $53.10K 10-Q · filed 2019-11-07 | $76.76K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $1.66K 10-Q · filed 2019-11-07 | $23.65K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-03-31 | $21.99K 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $36.10K 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2016-12-31 | $18.97K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |